Literature DB >> 26769917

Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation.

Brenda M Gannon1, Adrian Williamson1, Masaki Suzuki1, Kenner C Rice1, William E Fantegrossi2.   

Abstract

3,4-Methylenedioxypyrovalerone (MDPV) is a common constituent of illicit "bath salts" products. MDPV is a chiral molecule, but the contribution of each enantiomer to in vivo effects in mice has not been determined. To address this, mice were trained to discriminate 10 mg/kg cocaine from saline, and substitutions with racemic MDPV, S(+)-MDPV, and R(-)-MDPV were performed. Other mice were implanted with telemetry probes to monitor core temperature and locomotor responses elicited by racemic MDPV, S(+)-MDPV, and R(-)-MDPV under a warm (28°C) or cool (20°C) ambient temperature. Mice reliably discriminated the cocaine training dose from saline, and each form of MDPV fully substituted for cocaine, although marked potency differences were observed such that S(+)-MDPV was most potent, racemic MDPV was less potent than the S(+) enantiomer, and R(-)-MDPV was least potent. At both ambient temperatures, locomotor stimulant effects were observed after doses of S(+)-MDPV and racemic MDPV, but R(-)-MDPV did not elicit locomotor stimulant effects at any tested dose. Interestingly, significant increases in maximum core body temperature were only observed after administration of racemic MDPV in the warm ambient environment; neither MDPV enantiomer altered core temperature at any dose tested, at either ambient temperature. These studies suggest that all three forms of MDPV induce biologic effects, but R(-)-MDPV is less potent than S(+)-MDPV and racemic MDPV. Taken together, these data suggest that the S(+)-MDPV enantiomer is likely responsible for the majority of the biologic effects of the racemate and should be targeted in therapeutic efforts against MDPV overdose and abuse. U.S. Government work not protected by U.S. copyright.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26769917      PMCID: PMC4767395          DOI: 10.1124/jpet.115.229500

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  24 in total

1.  Chiral resolution and absolute configuration of the enantiomers of the psychoactive "designer drug" 3,4-methylenedioxypyrovalerone.

Authors:  Masaki Suzuki; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  Chirality       Date:  2015-02-26       Impact factor: 2.437

2.  Self-administration of optical isomers of amphetamine and methylamphetamine by rats.

Authors:  R A Yokel; R Pickens
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

4.  Stereoselective effects of cocaine.

Authors:  J.L. Katz; E. Tirelli; J.M. Witkin
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

5.  Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modifications.

Authors:  R A Glennon; M D Schechter; J A Rosecrans
Journal:  Pharmacol Biochem Behav       Date:  1984-07       Impact factor: 3.533

6.  Methcathione ("cat"): an enantiomeric potency comparison.

Authors:  R A Glennon; R Young; B R Martin; T A Dal Cason
Journal:  Pharmacol Biochem Behav       Date:  1995-04       Impact factor: 3.533

7.  Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations.

Authors:  William E Fantegrossi; Naoki Murai; Brian O Mathúna; Nieves Pizarro; Rafael de la Torre
Journal:  J Pharmacol Exp Ther       Date:  2009-03-10       Impact factor: 4.030

8.  In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.

Authors:  William E Fantegrossi; Brenda M Gannon; Sarah M Zimmerman; Kenner C Rice
Journal:  Neuropsychopharmacology       Date:  2012-11-08       Impact factor: 7.853

9.  Structure-activity studies on amphetamine analogs using drug discrimination methodology.

Authors:  R A Glennon; R Young; A E Hauck; J D McKenney
Journal:  Pharmacol Biochem Behav       Date:  1984-12       Impact factor: 3.533

10.  Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.

Authors:  D L Musso; N B Mehta; F E Soroko; R M Ferris; E B Hollingsworth; B T Kenney
Journal:  Chirality       Date:  1993       Impact factor: 2.437

View more
  42 in total

1.  Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.

Authors:  Harmony I Risca; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2018-12-15       Impact factor: 4.530

2.  Conditioned taste avoidance, conditioned place preference and hyperthermia induced by the second generation 'bath salt' α-pyrrolidinopentiophenone (α-PVP).

Authors:  Katharine H Nelson; Briana J Hempel; Matthew M Clasen; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2017-04-17       Impact factor: 3.533

3.  The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.

Authors:  Nicholas B Miner; James P O'Callaghan; Tamara J Phillips; Aaron Janowsky
Journal:  Neurotoxicol Teratol       Date:  2017-02-16       Impact factor: 3.763

4.  Characterization of the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone in male Sprague-Dawley rats.

Authors:  Michael D Berquist; Lisa E Baker
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

Review 5.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Authors:  Brenda M Gannon; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2018-09-29       Impact factor: 4.530

7.  Effects of orally self-administered bath salt constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice.

Authors:  Brenda M Gannon; Lauren N Russell; Meet S Modi; Kenner C Rice; William E Fantegrossi
Journal:  Drug Alcohol Depend       Date:  2017-08-04       Impact factor: 4.492

8.  Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice.

Authors:  Azizi Ray; Neha Milind Chitre; Cedrick Maceo Daphney; Bruce E Blough; Clinton E Canal; Kevin Sean Murnane
Journal:  Psychopharmacology (Berl)       Date:  2018-10-01       Impact factor: 4.530

9.  Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.

Authors:  Claudia J Woloshchuk; Katharine H Nelson; Kenner C Rice; Anthony L Riley
Journal:  Drug Alcohol Depend       Date:  2016-08-07       Impact factor: 4.492

10.  Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018.

Authors:  Benjamin M Ford; Christian V Cabanlong; Sherrica Tai; Lirit N Franks; Narsimha R Penthala; Peter A Crooks; Paul L Prather; William E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2019-03-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.